Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026
Pharma-Bio Serv reported Q3 revenue of approximately $2.3 million, up roughly $0.4 million versus the same period last year, with nine-month revenue of about $7.3 million, up approximately $0.5 million year over year. The company posted a narrow Q3 net loss of $14 thousand, an improvement of about $190 thousand from the prior year, while nine-month net income reached approximately $252 thousand, up roughly $352 thousand year over year.
Key figures
- Revenue
- 2300000
- Revenue Yoy
- up approximately $0.4 million vs the same period last year (Q3); nine-month revenue of $7.3 million up approximately $0.5 million
- Nine month revenue
- 7300000
- Nine month net income
- 252000
- Q3 net loss improvement yoy
- approximately $190 thousand
- Nine month net income improvement yoy
- approximately $352 thousand
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.